Methylcobalamin injection (Rozebalamin) latest price reference and application of medical insurance reimbursement policy

Methylcobalamin injection (Rozebalamin) is a drug developed by Japan's Eisai to treat ALS (amyotrophic lateral sclerosis). It is not currently on the market in China, so domestic patients are temporarily unable to purchase the drug directly through formal channels. Since it has not entered the domestic market, the drug has not yet been included in the scope of national medical insurance, and the medical insurance reimbursement policy and applicable conditions are still unknown. This also means that patients may need to obtain it through special channels or overseas purchasing agents for domestic use.

In overseas markets, the Japanese version of the original drug for methylcobalamin injection has been put on the market. The common specifications are 25mg/ bottles*8 bottles. Each box sells for about 2 about fifteen thousand yuan. Prices are greatly affected by exchange rate fluctuations, and because they are imported drugs, transportation and tariffs may also have an impact on the actual purchase cost. If patients need to use it for a long time, the overall treatment cost will be relatively high, and they need to make a financial budget in advance.

At present, there are no generic drugs of methylcobalamin injection on the market, whether in domestic or overseas markets, which means that the original drug is still the main source of drug acquisition, which also increases the difficulty of patient acquisition and the cost of treatment. For patients with ALS who require ongoing treatment, it is particularly important to obtain a stable supply of drugs and standardized medication guidance. Drug storage conditions and injection safety must also be considered.

Generally speaking, there are still major limitations in the availability and medical insurance applicability of Methylcobalamin Injection (Rozebalamin) in the domestic market. When choosing a treatment plan, patients should develop an individualized treatment plan based on overseas procurement channels, drug prices, medication safety and guidance from medical institutions to ensure the continuity and effectiveness of treatment.

Keyword tags:

Methylcobalamin injection, latest price, medical insurance reimbursement policy, domestic market, overseas drug purchase, original drug, economic burden

Reference materials:https://www.drugs.com/